Journal of Clinical PracticeJournal of Clinical PracticeКлиническая практика2220-30952618-8627Eco-Vector1174910.17816/clinpract10349-54ReviewsНаучные обзорыResearch ArticleThe strategy of surgical revascularization of coronary arteries in a multi-vessel lesionСтратегии хирургической реваскуляризации коронарного русла при многососудистом пораженииhttps://orcid.org/0000-0002-6027-2898BocharovAleksandr V.БочаровАлександр Владимирович
Russian Federation

Cand. Med. Sc., Chief of Department, Endovascular Surgeon

кандидат медицинских наук, заведующий отделением рентгенохирургических методов диагностики и лечения

bocharovav@mail.ruhttps://orcid.org/0000-0002-0530-3268PopovLeonid V.ПоповЛеонид Валентинович
Russian Federation

MD, PhD, professor, head of the Department of cardiac surgery

Доктор медицинских наук, профессор, заведующий отделением кардиохирургии

popovcardio@mail.ruKostroma regional clinical hospital named after Korolev E.I.Костромская областная клиническая больница имени Королева Е.И.National Medical and Surgical Center named after N.I. PirogovНациональный медико-хирургический центр имени Н.И. Пирогова0611201910349541504201903102019Copyright ©; 2019, Bocharov A.V., Popov L.V.Copyright ©; 2019, Бочаров А.В., Попов Л.В.2019Bocharov A.V., Popov L.V.Бочаров А.В., Попов Л.В.https://creativecommons.org/licenses/by-nc-nd/4.0https://clinpractice.ru/clinpractice/article/view/11749

This review presents the basic approaches for the surgical myocardial revascularization in patients with multivessel coronary lesions. The methods of coronary artery bypass grafting, balloon angioplasty, stenting using holometallic stents and drug-coated stents are discussed, the main studies comparing the above methods with each other and with the optimal drug therapy are presented. The concepts of complete and incomplete revascularization of the coronary bed are also explained.

В обзоре представлены основные методы хирургической реваскуляризации миокарда у больных с многососудистым поражением коронарного русла. Рассматриваются методы аортокоронарного шунтирования, баллонной ангиопластики, стентирования с использованием голометаллических каркасов и конструкций с лекарственным покрытием; приведены результаты основных исследований, сравнивающих вышеназванные методики между собой, а также с оптимальной медикаментозной терапией; раскрыты понятия полной и неполной реваскуляризации коронарного русла.

coronary heart diseasecoronary artery bypass graftingdrug-eluting coronary stentbare-metal stentoptimal drug therapyишемическая болезнь сердцааортокоронарное шунтированиекоронарный стент с лекарственным покрытиемголометаллический стентоптимальная медикаментозная терапияЛитвинова М.А. Анализ информативности различных методов диагностики ишемической болезни сердца // Здоровье и образование в XXI веке. — 2016. — Т.18. — №1. — С. 241–245. [Litvinova MA. Analysis of the information different methods of diagnosis coronary heart disease. Health and education millennium. 2016;18(1):241–245. (In Russ).]Task Force Members, Montalescot G, Sechtem U, et al. 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European society of cardiology. Eur Heart J. 2013;34(38):2949–3003. doi: 10.1093/eurheartj/eht296.Every NR, Maynard C, Cochran RP, et al. Characteristics, management, and outcome of patients with acute myocardial infarction treated with bypass surgery. Myocardial Infarction Triage and Intervention Investigators. Circulation. 1996;94(9 Suppl):1181–1186.Бабунашвили А.М., Иванов В.А. Хронические окклюзии коронарных артерий: анатомия, патофизиология, эндоваскулярное лечение. — М.: АСВ, 2012. — С. 90. [Babunashvili AM, Ivanov VA. Khronicheskie okklyuzii koronarnykh arteriy: anatomiya, patofiziologiya, endovaskulyarnoe lechenie. Moscow: ASV; 2012. Р. 90. (In Russ).]Prasad A, Rihal CS, Lennon RJ, et al. Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: a 25-year experience from the Mayo Clinic. J Am Coll Cardiol. 2007;49(15):1611–1618. doi: 10.1016/j.jacc.2006.12.040.Хайрутдинов Е.Р., Шушгушев З.Х., Макимкин Д.А., и др. Особенности эндоваскулярной реваскуляризации миокарда у больных ишемической болезнью сердца с многососудистым поражением коронарного русла // Клиническая медицина. — 2012. — Т.90. — №7. — С. 20–25. [Khairutdinov ER, Shugushev ZKh, Maksimkin DA, et al. Peculiarities of endovascular myocardial revascularization in patients with coronary heart disease and multivascular lesions in the coronary bed. Gazeta zhurnala Klinicheskaia meditsina. 2012;90(7):20–25. (In Russ).]Safley DM, House JA, Marso SP, et al. Improvement in survival following successful percutaneous coronary intervention of coronary chronic total occlusions: variability by target vessel. JACC Cardiovasc Interv. 2008;1(3):295–302. doi: 10.1016/j.jcin.2008.05.004.Vieira RD, Hueb W, Gersh BJ, et al. Effect of complete revascularization on 10-year survival of patients with stable multivessel coronary artery disease: MASS II trial. Circulation. 2012;126(11 Suppl 1):S158–163. doi: 10.1161/CIRCULATIONAHA.111.084236.BARI 2D Study Group, Frye RL, August P, et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. N Engl J Med. 2009;360(24):2503–2515. doi: 10.1056/NEJMoa0805796.Puskas JD, Pawale A, Sharma SK. Hybrid coronary revascularization: a new treatment paradigm for selected patients with multivessel coronary artery disease. JACC Cardiovasc Interv. 2014;7(11):1284–1286. doi: 10.1016/j.jcin.2014.06.013.Silber S, Albertsson P, Avilés FF, et al. Guidelines for percutaneous coronary interventions. The task force for percutaneous coronary interventions of the European Society of Cardiology. Eur Heart J. 2005;26(8):804–847. doi: 10.1093/eurheartj/ehi138.Windecker S, Kolh P, Alfonso F, et al. [2014 ESC/EACTS Guidelines on myocardial revascularization. (In Polish).] Kardiol Pol. 2014;72(12):1253–1379. doi: 10.5603/KP.2014.0224.Serruys PW, Morice MC, Kappetein AP, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med. 2009;360(10):961–972. doi: 10.1056/NEJMoa0804626.Kurbaan AS, Bowker TJ, Ilsley CD, Rickards AF. Impact of postangioplasty restenosis on comparisons of outcome between angioplasty and bypass grafting. Coronary angioplasty versus bypass revascularisation investigation (CABRI) investigators. Am J Cardiol. 1998;82(3):272–276. doi: 10.1016/s0002-9149(98)00331-2.King SB, Lembo NJ, Weintraub WS, et al. A randomized trial comparing coronary angioplasty with coronary bypass surgery. Emory angioplasty versus surgery trial (EAST). N Engl J Med. 1994;331(16):1044–1050. doi: 10.1056/NEJM199410203311602.BARI Investigators. The final 10-year follow-up results from the BARI randomized trial. J Am Coll Cardiol. 2007;49(15):1600–1606. doi: 10.1016/j.jacc.2006.11.048.Topol EJ. Textbook of interventional cardiology. 5th ed. Saunders Elsevier, Philadelphia; 2008. Рр. 417–430.Participants CT. First-year results of CABRI (Coronary Angioplasty vs. Bypass Revascularization Investigation). Lancet. 1995;346:1179–1184. doi: 10.1016/s0140-6736(95)92896-0.Hamm CW, Reimers J, Ischinger T, et al. A randomized study of coronary angioplasty compared with bypass surgery in patients with symptomatic multivessel coronary disease. German angioplasty bypass surgery investigation (GABI). N Engl J Med. 1994;331(16):1037–1043. doi: 10.1056/NEJM199410203311601.Henderson RA. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. randomised intervention treatment of Angina. Lancet. 1998;352(9138):1419–1425. doi: 10.1016/s0140-6736(98)03358-3.Rodriguez AE, Baldi J, Fernández Pereira C, et al. Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II). J Am Coll Cardiol. 2005;46(4):582–588. doi: 10.1016/j.jacc.2004.12.081.Hueb W, Lopes N, Gersh BJ, et al. Ten-year follow-up survival of the medicine, angioplasty, or surgery study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease. Circulation. 2010;122(10):949–957. doi: 10.1161/CIRCULATIONAHA.109.911669.Serruys PW, Ong AT, van Herwerden LA, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the arterial revascularization therapies study (ARTS) randomized trial. J Am Coll Cardiol. 2005;46(4):575–581. doi: 10.1016/j.jacc.2004.12.082.Morrison DA, Sethi G, Sacks J, et al. Percutaneous coronary intervention versus coronary artery bypass graft surgery for patients with medically refractory myocardial ischemia and risk factors for adverse outcomes with bypass: a multicenter, randomized trial. Investigators of the department of veterans affairs cooperative study #385, the Angina with extremely serious operative mortality evaluation (AWESOME). J Am Coll Cardiol. 2001;38(1):143–149. doi: 10.1016/s0735-1097(01)01366-3.Rodriguez AE, Maree AO, Mieres J, et al. Late loss of early benefit from drug-eluting stents when compared with bare-metal stents and coronary artery bypass surgery: 3 years follow-up of the ERACI III registry. Eur Heart J. 2007;28(17):2118–2125. doi: 10.1093/eurheartj/ehm297.Serruys PW, Onuma Y, Garg S, et al. Assessment of the SYNTAX score in the syntax study. EuroIntervention. 2009;5(1):50–56. doi: 10.4244/eijv5i1a9.Thuijs DJ, Mohr FW, Serruys PW, et al. 10-year survival after bypass surgery versus drug-eluting stents: preliminary results of the randomized SYNTAX extended survival study «SYNTAXES». Presented at: TCT 2018; September 21. San Diego, USA; 2018. Available from: https://www.acc.org/~/media/Clinical/PDF-Files/Approved-PDFs/2018/09/21/TCT-2018-Slides/Sept24-Mon/3pmET_SYNTAXES-tct-2018.pdf.Bonaa KH, Mannsverck J, Wiseth R, et al. Drug-eluting or bare-metal stents for coronary artery disease. N Engl J Med. 2016;375(13):1242–1252. doi: 10.1056/NEJMoa1607991.Boden WE, O’Rourke RA, Teo KK, et al. Optimal medical therapy with or without PCI for stable coronary disease. N Engl J Med. 2007;356(15):1503–1516. doi: 10.1056/NEJMoa070829.Shaw LJ, Berman DS, Maron DJ, et al. Optimal medical therapy with or without percutaneous coronary intervention to reduce ischemic burden: results from the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial nuclear substudy. Circulation. 2008;117(10):1283–1291. doi: 10.1161/CIRCULATIONAHA.Al-Lamee R, Thompson D, Dehbi HM, et al. Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial. Lancet. 2018;391(10115):31–40. doi: 10.1016/S0140-6736(17)32714-9.Maron DJ, Hochman JS, et al.; ISCHEMIA Trial Research Group. International study of comparative health effectiveness with medical and invasive approaches (ISCHEMIA) trial: rationale and design. Am Heart J. 2018;201:124–135. doi: 10.1016/j.ahj.2018.04.011.